SAB Biotherapeutics (SABS) Total Debt (2020 - 2025)
SAB Biotherapeutics (SABS) reported Total Debt of $138,554 for Q1 2025, down 83.4% from $835,467 a year earlier and down 49.8% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Total Debt (2020 - 2025) Analysis & Trends
At the end of FY2024, SAB Biotherapeutics posted Total Debt of $275,849, down 73.7% from FY2023.
- Total Debt has declined for three consecutive years, with a four-year compound annual growth rate of -21.1% (FY2020 to FY2024).
- By year, Total Debt came in at $1.05 million in FY2023 (-20.0%), $1.31 million in FY2022 (-26.8%), $1.8 million in FY2021 (+152.8%) and $710,768 in FY2020.
- The Q1 2025 figure ranks as the lowest quarterly Total Debt since Q2 2023.
- Year over year, Total Debt gained in two of the last six quarters, with growth averaging 50.2%.
- The high point for year-over-year Total Debt in five years was Q2 2024 (growth of 450.4%); the low point was Q1 2025 (a decline of 83.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 54.91 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 49.04 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 70.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 53.91 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.59 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 32.35 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 57.30 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 26.25 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 63.19 Bn |
| 10 | SAB Biotherapeutics | 223.71 Mn | -193.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 138,554.00 |
| Dec 31, 2024 | 275,849.00 |
| Jun 30, 2024 | 615,818.00 |
| Mar 31, 2024 | 835,467.00 |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 541,644.00 |
| Jun 30, 2023 | 111,894.00 |
| Mar 31, 2023 | 444,478.00 |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 25,013.00 |
| Jun 30, 2022 | 278,441.00 |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | 1.80 Mn |
| Dec 31, 2020 | 1.42 Mn |
API Access
SAB Biotherapeutics Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();